| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/16/2014 | US20140017231 Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy |
| 01/16/2014 | US20140017226 Treatment of multiple sclerosis with combination of laquinimod and fampridine |
| 01/16/2014 | US20140017220 Treatment of ophthalmic conditions |
| 01/16/2014 | US20140017219 Nitro fatty acids - neuroprotection and/or inhibition of cognitive decline |
| 01/16/2014 | US20140017215 Genetically Modified Pigs for Xenotransplantation of Vascularized Xenografts and Derivatives Thereof |
| 01/16/2014 | US20140017204 Transfection of Mesothelium Body Cavity Lining with Gene Agents Followed by Chemotharapy to Treat Cancer of Organs in the Body Cavity |
| 01/16/2014 | US20140017199 Modulators of pharmacokinetic properties of therapeutics |
| 01/16/2014 | US20140017198 Inhibitors of hepatitis c virus |
| 01/16/2014 | US20140017197 Anti-CD19 Antibodies |
| 01/16/2014 | US20140017196 Compositions and methods of use of phorbol esters |
| 01/16/2014 | US20140017194 Compositions And Methods Of Use Of Phorbol Esters |
| 01/16/2014 | US20140017193 Methods for treating nervous system injury and disease |
| 01/16/2014 | US20140017177 Silene capensis for inhibiting cravings |
| 01/16/2014 | US20140017166 Material and methods for treating or preventing her-3 associated diseases |
| 01/16/2014 | DE202011110392U1 Oral verabreichbare pharmazeutische Zusammensetzung zur behandlung von Menstruationsschmerzen, die von übermäßigem menstruellem Blutverlust begleitet sind Orally administrable pharmaceutical composition for the treatment of menstrual cramps, which are accompanied by excessive menstrual blood loss |
| 01/15/2014 | EP2684574A1 Compositions and methods for treating vaginal infections and pathogenic vaginal biofilms |
| 01/15/2014 | EP2684569A1 A composition for treatment of advanced prostate cancer |
| 01/15/2014 | EP2684563A1 Antibacterial or preserving composition containing 3-butoxy-1,2-propanediol |
| 01/15/2014 | EP2683737A1 Extracellular targeted drug conjugates |
| 01/15/2014 | EP2683377A1 Combination therapies for hematologic malignancies |
| 01/15/2014 | EP2683376A2 Methods for treating diseases using isoindoline compounds |
| 01/15/2014 | EP2683372A1 Methods and compositions for treating hyperuricemia and metabolic disorders associated with hyperuricemia |
| 01/15/2014 | EP2683245A1 Methods and compositions for treating depression using cyclobenzaprine |
| 01/15/2014 | EP1037926B1 TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 01/15/2014 | DE202011110356U1 Behandlung von Endometriose durch intravaginale Verabreichung einer niedrigen Dosis eines selektiven Progesteronrezeptormodulators, eines Antigestagens oder eines Antigestagen-Wirkstoffes Treatment of endometriosis by intravaginal administration of a low dose of a selective progesterone receptor modulator, an anti-progestin or progestin anti-drug |
| 01/15/2014 | DE202011110355U1 Behandlung von Uterusmyomen durch intravaginale Verabreichung einer niedrigen Dosis eines selektiven Progesteronrezeptormodulators, eines Antigestagens oder eines Antigestagen-Wirkstoffes Uterine fibroid treatment by intravaginal administration of a low dose of a selective progesterone receptor modulator, an anti-progestin or progestin anti-drug |
| 01/15/2014 | CN103517898A Novel 3-hydroxyisothiazole 1-oxide derivative |
| 01/15/2014 | CN103517718A Conjugates of an il-2 moiety and a polymer |
| 01/15/2014 | CN103505735A Composition containing r-aminobutyric acid, taurine and antiepileptic drugs |
| 01/15/2014 | CN103505734A Composition containing r-aminobutyric acid and antiepileptic drugs |
| 01/15/2014 | CN103505733A Oral liquid preparation with macrolides medicine as active component |
| 01/15/2014 | CN103505732A Tumor treatment synergism combination drug |
| 01/15/2014 | CN103505731A Applications of 1 type cysteinyl leukotriene receptor antagonist on preparation of medicament for treating the Alzheimer disease |
| 01/15/2014 | CN103505728A Inhibition of alternative complement pathway for treatment of traumatic brain injury, spinal cord injury and related conditions |
| 01/15/2014 | CN103505441A Oral solid preparation containing biguanides and acarbose and preparation method thereof |
| 01/15/2014 | CN102732515B Nucleotide sequence and application thereof |
| 01/15/2014 | CN102603866B Oligopeptide-based pH-sensitive amphoteric ion and application thereof in medicament |
| 01/14/2014 | US8629140 Hypotensive lipid and timolol compositions and methods of using same |
| 01/14/2014 | US8629127 Compositions and methods of treatment for inflammatory diseases |
| 01/14/2014 | US8629117 Method for stimulating the immune system |
| 01/14/2014 | US8628809 Method of inducing mucosal immune response to antigen with Dioscorea polysaccharides adjuvant |
| 01/14/2014 | US8628785 Method for augmenting the immunogenicity of an antigen |
| 01/14/2014 | US8628775 Methods of reducing T cell-mediated immune responses with multimeric P-selectin and/or E-selectin compounds |
| 01/14/2014 | US8628770 Slimming cosmetic composition containing a substance inducing the production of IL-6 |
| 01/14/2014 | CA2669019C Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
| 01/14/2014 | CA2548771C A medical solution, a method for producing said medical solution and use thereof |
| 01/14/2014 | CA2519875C Method of tumor regression with vegf inhibitors |
| 01/14/2014 | CA2373375C Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 01/09/2014 | WO2014008242A1 The use of interleukin-11 to protect against ischemia and reperfusion injury |
| 01/09/2014 | WO2014008054A2 Novel insecticidal proteins and methods for their use |
| 01/09/2014 | WO2014007369A1 Fgfr2 fusion gene |
| 01/09/2014 | WO2014007217A1 Antitumor effect potentiator composed of imidazooxazine compound |
| 01/09/2014 | WO2014006867A1 Composition containing biologically active substance |
| 01/09/2014 | WO2014006115A1 Combination of a phosphoinositide 3-kinase inhibitor and an inhibitor of the il-8/cxcr interaction |
| 01/09/2014 | WO2014006020A1 Gpbp-1 inhibition and its therapeutic use |
| 01/09/2014 | WO2013173506A3 Kinase inhibitors for use in the treatment of muscular degradation |
| 01/09/2014 | US20140011887 Materials and methods for improving alcohol metabolism and alleviating the effects of hangovers |
| 01/09/2014 | US20140011885 Organic Compounds |
| 01/09/2014 | US20140011884 Use of s1p receptor modulator |
| 01/09/2014 | US20140011878 High-dose glycine as a treatment for obsessive-compulsive disorder and obsessive-compulsive spectrum disorders |
| 01/09/2014 | US20140011873 Compositions and methods of use of phorbol esters for the treatment of stroke |
| 01/09/2014 | US20140011868 Use of Simalikalactone E as an Anticancer Agent |
| 01/09/2014 | US20140011853 Substituted 3-(biphenyl-3-yl)-8,8-difluoro-4-hydroxy-1-azaspiro[4.5]dec-3-en-2-ones for therapy |
| 01/09/2014 | US20140011841 Treatment of energy utilization disease |
| 01/09/2014 | US20140011825 Compounds and Compositions as Protein Kinase Inhibitors |
| 01/09/2014 | US20140011819 Novel selective pi3k delta inhibitors |
| 01/09/2014 | US20140011802 Fused Aminodihydrothiazine Derivatives |
| 01/09/2014 | US20140011798 Imidazopyrrolidinone compounds |
| 01/09/2014 | US20140011784 Method and composition for treating asthma |
| 01/09/2014 | US20140011783 Organic compounds |
| 01/09/2014 | US20140011775 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-ht6 antagonists |
| 01/09/2014 | US20140011772 Compositions and methods for treating conditions associated with neuronal dysfunction |
| 01/09/2014 | US20140011770 Compositions and methods for inhibition of the jak pathway |
| 01/09/2014 | US20140011761 Modulating Endoplasmic Reticulum Stress in the Treatment of Tuberous Sclerosis |
| 01/09/2014 | US20140011758 Isoxazoline derivatives as antiparasitic agents |
| 01/09/2014 | US20140011745 Organ preconditioning, arrest, protection, preservation and recovery (2) |
| 01/09/2014 | US20140011244 Method for Producing Probiotically Derived Compounds |
| 01/09/2014 | US20140011181 Organ arrest, protection, preservation and recovery |
| 01/09/2014 | US20140010898 New positive allosteric modulators of nicotinic acetylcholine receptor |
| 01/09/2014 | US20140010897 New positive allosteric modulators of nicotinic acetylcholine receptor |
| 01/09/2014 | US20140010892 Benzimidazole derivatives and their use as protein kinase inhibitors |
| 01/09/2014 | US20140010891 Method of making demineralized bone particles |
| 01/09/2014 | US20140010873 Abuse deterrent pharmaceutical compositions for controlled release |
| 01/09/2014 | US20140010870 Pharmaceutical formulation comprising inositol |
| 01/09/2014 | US20140010867 Treatment of proliferative disorders with a chemiluminescent agent |
| 01/09/2014 | US20140010865 Enhanced immune response in bovine species |
| 01/09/2014 | US20140010863 Liposomes for protection against toxic compounds |
| 01/09/2014 | US20140010859 Barley protein microcapsules |
| 01/09/2014 | US20140010844 Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers |
| 01/09/2014 | US20140010830 Non-Coding Immunomodulatory DNA Construct |
| 01/09/2014 | US20140010821 Use of CD83 in combination therapies |
| 01/09/2014 | US20140010819 Method for correcting immunopathological reactions and a medicament |
| 01/09/2014 | US20140010817 Novel Antibodies and Uses Thereof |
| 01/09/2014 | US20140010806 Treatment of Ocular Diseases |
| 01/09/2014 | US20140010789 Compositions and methods for modulating emt and uses thereof |
| 01/09/2014 | US20140010784 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 01/09/2014 | US20140010783 Antiviral compounds |
| 01/09/2014 | US20140010780 Vaccine immunotherapy for immune suppressed patients |
| 01/09/2014 | US20140010779 Vaccine immunotherapy for immune suppressed patients |
| 01/09/2014 | US20140010759 Tumor specific anitbodies and uses therefor |